Zzbeacon,Zayna [MR ]
|
|
- Randolph Greene
- 5 years ago
- Views:
Transcription
1 AALL1131-DS INDUCTION HR-ALL, DAYS 1-14 Properties Cycle 1 9/27/2012 through 10/10/2012 (14 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release Labs CBC and differential Release Release Comprehensive metabolic panel Release Bilirubin, direct (GH L Q YH) Release CSF cell count with differential (L YH) Release Immunoglobulin G Release Varicella-zoster virus by PCR (BH GH YH) Release Release Release Release 25 ml/hr, Intravenous, CONTINUOUS PRN, Other, as needed to keep vein open., Starting Release Release Release 0.15 mg/kg 35.8 kg (Treatment plan actual weight) = 5.38 mg, IV Push, EVERY 4 HOURS PRN, Nausea or vomiting, Starting midazolam (VERSED) injection 1.79 mg Release 0.05 mg/kg 35.8 kg (Treatment plan actual weight) = 1.79 mg, Intravenous, PRN, for sedation for procedure., Starting, For 3 doses fentanyl PF (SUBLIMAZE) injection 36 mcg 1 mcg/kg 35.8 kg (Treatment plan actual weight) = 36 mcg, IV Push, PRN, for sedation for procedure., Starting, For 3 doses Release naloxone (NARCAN) injection 0.36 mg 10 mcg/kg 35.8 kg (Treatment plan actual weight) = 0.36 mg, IV Push, PRN, Opioid Reversal, Starting, For 10 doses May repeat every 2-3 minutes. Release flumazenil (ROMAZICON) injection mg Release 0.01 mg/kg 35.8 kg (Treatment plan actual weight) = mg, Intravenous, PRN, for benzodiazepine reversal., Starting, For 5 doses Ordered dose of 0.01 mg/kg PRN exceeds the recommended single dose limit of 0.2 mg. 9/27/2012 3:37:24 PM Page 1 of 5
2 lidocaine (LMX) 4 % cream Topical, PRN, for procedure sites., Starting Release Release cytarabine (CYTOSAR) in sodium chloride 0.9 % 5 ml PF INTRATHECAL chemo injection Intrathecal, ONCE, Starting, For 1 dose Release Prepared in preservative-free 0.9% sodium chloride. Administration is by MD or other licensed oncology provider. leucovorin (WELLCOVORIN) tablet 5 mg 5 mg/m m2 (Treatment plan actual BSA) = 5 mg, Oral, EVERY 12 HOURS, Starting 48 hours after treatment start time Release 5 mg/m2 (5.8 mg = 1.16 tablet) cannot be administered using available products. The nearest available dose is 5 mg (4.31 mg/m2). vincristine (ONCOVIN) 1.7 mg in sodium chloride 0.9 % 25 ml chemo Release infusion 1.5 mg/m m2 (Treatment plan actual BSA) = 1.7 mg, Intravenous, for 5 Minutes, ONCE, Starting, For 1 dose Vesicant-monitor infusion site frequently. Fatal if given intrathecally. 2.5 ml = 250 Units, Intra-Catheter, PRN, Catheter Care, for Portacath., Starting 2.5 ml = 25 Units, Intra-Catheter, PRN, for broviac/picc catheter use., Starting Release Release Release draw/administration., Starting Release Day 4, Cycle 1 Planned for 9/30/2012 Drug Reaction Instructions Monitor for drug related reactions: if reaction occurs stop infusion, notify oncology provider, assess vitals, administer emergency meds as ordered. 25 ml/hr, Intravenous, CONTINUOUS PRN, Other, as needed to keep vein open., Starting 9/27/2012 3:37:24 PM Page 2 of 5
3 0.15 mg/kg 35.8 kg (Treatment plan actual weight) = 5.38 mg, IV Push, EVERY 4 HOURS PRN, Nausea or vomiting, Starting PEGaspargase (ONCASPAR) 2,903 Int'l Units in sodium chloride 0.9 % 100 ml chemo infusion 2,500 Int'l Units/m m2 (Treatment plan actual BSA) = 2,903 Int'l Units, Intravenous, for 1 Hours, ONCE, Starting, For 1 dose 2.5 ml = 250 Units, Intra-Catheter, PRN, Catheter Care, for Portacath., Starting 2.5 ml = 25 Units, Intra-Catheter, PRN, for broviac/picc catheter use., Starting draw/administration., Starting Emergency Medications hydrocortisone sodium succinate (Solu-CORTEF) injection 71.5 mg 2 mg/kg 35.8 kg (Treatment plan actual weight) = 71.5 mg, IV Push, ONCE PRN, for hypersensitivity reaction, Starting, For 1 dose diphenhydramine (BENADRYL) injection 36 mg 1 mg/kg 35.8 kg (Treatment plan actual weight) = 36 mg, IV Push, ONCE PRN, Other, for hypersensitivity reactions, Starting, For 1 dose Give by IV Push no faster than 25 mg/min EPINEPHrine (PF) (ADRENALIN) injection 0.36 mg 0.01 mg/kg 35.8 kg (Treatment plan actual weight) = 0.36 mg, Intramuscular, EVERY 15 MIN PRN, for anaphylaxis leading to hypotension or breathing difficulty., Starting Ordered dose of 0.01 mg/kg EVERY 15 MIN PRN exceeds the recommended single dose limit of 0.3 mg. Labs Day 8, Cycle 1 Planned for 10/4/2012 CBC and differential CSF cell count with differential (L YH) 9/27/2012 3:37:24 PM Page 3 of 5
4 25 ml/hr, Intravenous, CONTINUOUS PRN, Other, as needed to keep vein open., Starting midazolam (VERSED) injection 1.79 mg 0.05 mg/kg 35.8 kg (Treatment plan actual weight) = 1.79 mg, Intravenous, PRN, for sedation for procedure., Starting, For 3 doses fentanyl PF (SUBLIMAZE) injection 36 mcg 1 mcg/kg 35.8 kg (Treatment plan actual weight) = 36 mcg, IV Push, PRN, for sedation for procedure., Starting, For 3 doses naloxone (NARCAN) injection 0.36 mg 10 mcg/kg 35.8 kg (Treatment plan actual weight) = 0.36 mg, IV Push, PRN, Opioid Reversal, Starting, For 10 doses May repeat every 2-3 minutes. flumazenil (ROMAZICON) injection mg 0.01 mg/kg 35.8 kg (Treatment plan actual weight) = mg, Intravenous, PRN, for benzodiazepine reversal., Starting, For 5 doses Ordered dose of 0.01 mg/kg PRN exceeds the recommended single dose limit of 0.2 mg. lidocaine (LMX) 4 % cream Topical, PRN, for procedure sites., Starting 0.15 mg/kg 35.8 kg (Treatment plan actual weight) = 5.38 mg, IV Push, EVERY 4 HOURS PRN, Nausea or vomiting, Starting methotrexate in sodium chloride 0.9 % 5 ml PF INTRATHECAL chemo injection Intrathecal ONCE, Starting, For 1 dose Prepared in preservative-free 0.9% sodium chloride. Administration is by MD or other licensed oncology provider. vincristine (ONCOVIN) 1.7 mg in sodium chloride 0.9 % 25 ml chemo infusion 1.5 mg/m m2 (Treatment plan actual BSA) = 1.7 mg, Intravenous, for 5 Minutes, ONCE, Starting, For 1 dose Vesicant-monitor infusion site frequently. Fatal if given intrathecally. 2.5 ml = 250 Units, Intra-Catheter, PRN, Catheter Care, for Portacath., Starting 2.5 ml = 25 Units, Intra-Catheter, PRN, for broviac/picc catheter use., Starting draw/administration., Starting 9/27/2012 3:37:24 PM Page 4 of 5
5 9/27/2012 3:37:24 PM Page 5 of 5
Zzbeacon,Zayna [MR ]
AALL1131 MAINTENANCE, ARM B, HR-ALL Properties Laboratory and Take-Home Medications 9/26/2012, Planned Laboratory and Take-Home Medications Planned for 9/26/2012 Release Take-Home Medications prednisone
More informationZzbeacon,Zayna [MR ]
AALL1131 INTERIM MAINTENANCE, HR-ALL, ARM B, HD MTX Properties Cycle 1 9/27/2012 through 11/28/2012 (63 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release CBC and differential Release Release
More informationRITUXIMAB RHEUMATOLOGY VASCULITIS
. PHYSICIAN (Patient Sticker) ORDER SET : CDH 208-237 Approved - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility Name:
More informationPHYSICIAN ORDER SET : Patient: DOB: Gender: Patient Phone #: Height: Weight:
. (Patient Sticker) CDH 208-203 Approved 2/18 - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility Name: Ordering Provider:
More informationINFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE WEEKS 0, 2, 6)
. INFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE CDH 208-211 Approved 2/18 - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility
More informationPHYSICIAN ORDERS Diagnosis
PICU PROCEDURE PLAN PHYSICIAN S Diagnosis Weight Allergies DETAILS Admit/Discharge/Transfer Patient Status Pt Status: Inpatient (LOS > 2 midnights) Pt Status: Observation (LOS < 2 midnights) Patient Care
More informationPEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL
PEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL HARBOR-UCLA MEDICAL CENTER PEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL SECTION Preface Disclaimer Nonpharmacologic Methods Table of Contents PAGE i ii iii
More informationNeurosurgery Pre-Op [1710] Patient Name MRN. General. Nursing. Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT [ ] Other
Neurosurgery Pre-Op [1710] Patient Name MRN General Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT Inpatient Only Procedure (Single Response) ( ) Admit to Inpatient Diagnosis:
More informationINPATIENT INTERVENTIONAL RADIOLOGY PLAN - Phase: Pre-Procedure Orders
- Phase: Pre-Procedure Orders DETAILS Patient Care Obtain Consent If one is not present on chart today. Vital Signs Per Policy Insert Peripheral Line T;N, Start IV on right side If left radial access is
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationSample. Affix patient label within this box.
Instructions for completing orders: Determine PRAM Clinical Score as per the Alberta Acute Childhood Asthma Pathway for Emergent/Urgent Care and select orders based on PRAM Score. Custom orders can be
More informationPOST TEST: PROCEDURAL SEDATION
POST TEST: PROCEDURAL SEDATION Name: Date: Instructions: Complete the Post-Test (an 85% is required to pass). If there are areas that you are unsure of, please review the relevant portions of the learning
More informationDrug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension
More information(31189) Hypothermia Initiation Phase One
Hypothermia Initiation Phase One Diagnosis Allergies For hypothermia tracking purposes only. Please do not uncheck.- Required Cardiac Emergency Tracking For hypothermia tracking purposes only. Consults
More informationANAPLASTIC LARGE CELL LYMPHOMA TREATMENT ROAD MAP (Modified ALCL99)
ANAPLASTIC LARGE CELL LYMPHOMA TREATMENT ROAD MAP (Modified ALCL99) CLASSIFICATION OF TREATMENT GROUPS: 1. Isolated Skin lesions, < 5 skin lesions. Treatment course: ( No treatment, wait and see approach)
More informationAppendix A: Pharmacologic approaches to pain management during MVA
Pain medication Though the medications shown below are commonly used for pain management during uterine evacuation, many other options exist. This table does not cover general anesthetic agents. Both anxiolytics
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationADULT Updated: September 4, 2018
Updated: September 4, 2018 Regimen Reference Order ARIA: LYMP [R-CHOP alt. R-DHAP] Planned Course: Indication for Use: Every 21 days for 6 cycles (R-CHOP given on cycles 1, 3 and 5; R-DHAP given on cycles
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase: Pediatric Spine Surgery General Orders
- Phase: Pediatric Spine Surgery General Orders PHYSICIAN S Diagnosis Weight Allergies Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert
More informationPharmacology Drug Dosage Calculations
Pharmacology Drug Dosage Calculations Overview Abbreviations Metric Conversions Desired Dose Concentrations Drip Rates Medications (Dopamine and Lidocaine) Abbreviations cc- cubic centimeter DD- Desired
More informationLYIVAC (Magrath B) + R (rituximab) [To be used after LYCODOX-M (Magrath A) + R]
Page 1 of 7 PPO FOR THE TREATMENT OF BURKITT LYMPHOMA AND LEUKEMIA LYIVAC (Magrath B) + R (rituximab) [To be used after LYCODOX-M (Magrath A) + R] DAY DATE CHEMOTHERAPY 1 Start signature sheet and prednisolone
More informationDEEP SEDATION TEST QUESTIONS
Mailing Address: Phone: Fax: The Study Guide is provided for those physicians eligible to apply for Deep Sedation privileges. The Study Guide is approximately 41 pages, so you may consider printing only
More informationChapter 19. Media Directory. Topical (Surface) Anesthesia. Spinal Anesthesia. Nerve-Block Anesthesia. Infiltration (Field-Block) Anesthesia
Chapter 19 Drugs for Local and General Anesthesia Slide 18 Media Directory Lidocaine Animation Upper Saddle River, New Jersey 07458 All rights reserved. Topical (Surface) Anesthesia Creams, sprays, suppositories
More information0.5 4 mcg/kg/hour. 4 mcg/kg/hour mg/kg/hour. 0.2 mg/kg/hour
PURPOSE* This guideline is intended to provide information about common critical care s in the pediatric emergency department. Information includes drug name, class, starting dose, titration information,
More informationAntiallergics and drugs used in anaphylaxis
Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing
More informationPICU Therapeutic Hypothermia Post Cardiac Arrest Re Warming Phase
Arrest Re Warming Phase Weight Allergies Patient Care ***After 24 hours initiate re warming (or after 72 hours for an infant less than one month old)*** PICU Re Warming Protocol ***See Reference Text***
More informationSAALT3W Sarcoma Dr. Meg Knowling. Protocol Code Tumour Group Contact Physician
BCCA Protocol Summary for Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vincristine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at a THREE
More informationPEDIATRIC ARGININE CLONIDINE STIMULATION TEST PLAN
Diagnosis Weight Allergies Patient Care Arginine Clonidine Stimulation Test Guid (Arginine Clonidine Stimulation Test Guidelines) See Reference Guidelines. Vital Signs Routine, q1h, With BP, During the
More informationWHS POSTOPERATIVE POWERPLAN CHANGES
Medications simplified and standardized to improve safety and effectiveness in the management of pain, itching, nausea/vomiting. Management: o The Anesthesiologist will continue to manage pain in the PACU.
More informationALL CONSOLIDATION- Cycle 3 (25-60 years)
ALL CONSOLIDATION- (25-60 years) INDICATION Adult Acute Lymphoblastic Leukaemia (ALL) in remission not eligible for allogeneic transplantation This protocol is suitable for patients aged 25-60 years. It
More informationUTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH
Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the
More informationInfusion of intravenous gamma globulin (immunoglobulins)
Infusion of intravenous gamma globulin (immunoglobulins) OBJECTIVES Intravenous gamma globulin therapy is indicated for replacement therapy in patients with primary and secondary antibody deficiency syndromes.
More informationADMINISTRATIVE POLICY AND PROCEDURE MANUAL. Subject: Moderate Sedation/Analgesia- Procedural ( Conscious Sedation ) Policy
BRYN MAWR HOSPITAL LANKENAU HOSPITAL PAOLI HOSPITAL Working Together to Serve the Community ADMINISTRATE POLICY AND PROCEDURE MANUAL Subject: Moderate Sedation/Analgesia- Procedural ( Conscious Sedation
More informationMellen Center Approach to Ocrelizumab (Ocrevus)
Mellen Center Approach to Ocrelizumab (Ocrevus) Q: What is mechanism of action of ocrelizumab? A; Ocrelizumab is a novel humanized monoclonal anti-cd20 antibody constructed with recombinant DNA techniques
More informationAnalgesic-Sedatives Drug Dose Onset
Table 4. Commonly used medications in procedural sedation and analgesia Analgesic-Sedatives Fentanyl Morphine IV: 1-2 mcg/kg Titrate 1 mcg/kg q3-5 minutes prn IN: 2 mcg/kg Nebulized: 3 mcg/kg IV: 0.05-0.15
More informationADENOSINE (Adenocard) VO = Intermediate Paramedic. ALBUTEROL SULFATE VO = EMT, EMT-IV, Intermediate Paramedic
ADENOSINE (Adenocard) ALBUTEROL SULFATE VO = EMT,, AMIODARONE (Cordarone) -except in cardiac arrest ASPIRIN EMT, ATROPINE SULFATE -except in cardiac arrest 1 ST dose 6 mg IVP, 2 ND dose 12 mg IVP, 3 rd
More informationTHROMBOLYTIC THERAPY FOR PERIPHERAL OCCLUSION
THROMBOLYTIC THERAPY FOR PERIPHERAL OCCLUSION PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer ***PROVIDER MUST CHECK MEDICATION LIST PRIOR TO PLACING THESE S*** Patient Care Vital Signs
More informationAppendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline
Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline 1. Pharmacist to order Narcotic Withdrawal Scores QH X 4 hours, then per table below: Narcotic Withdrawal Score
More informationIR Central Venous Access [ ] Pre Procedure
IR Central Venous Access [1050200001] Pre Procedure Case Request/Scheduling Procedure Enter IR Case Request if not already completed (All hospitals except Grant Medical Center) [ ] Case Request IR Lab
More information2
1 2 3 4 5 6 7 8 Please check regional policy on this Tetracaine and Morgan lens may be optional in region *Ketamine and Fentanyl must be added to your CS license if required by your region *Midstate will
More informationConsent Laboratory Transfuse RBC
Peds Blood Product Infusion Order Set (386) [386] Blood product review will be performed unless exclusion criteria met. MD: Please note if transfusion giv en outside of parameter, please justify use in
More informationMath Practice for Paramedic Students
Math Practice for Paramedic Students 1. You are responsible for providing the proper dose of etomidate to your partner so that he can initiate the RSI procedure for your patient. The patient weighs an
More informationASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY London, October 2006 Doc. Ref: EMEA/405166/2006 DISCLAIMER The Paediatric Working Party
More informationVAN WERT COUNTY HOSPITAL. Policy/Procedure: Departmental No.: N 11-36A. Issue Date: 7-97 By: Nursing No. of Pages: 6
VAN WERT COUNTY HOSPITAL Policy/Procedure: Departmental No.: N 11-36A Issue Date: 7-97 By: Nursing No. of Pages: 6 Reviewed: 9-14, 8-11, 8-10 Revised: 9-14 Distribution List: All Nursing Departments Concurrence:
More informationPHYSICIAN PROCEDURAL SEDATION AND ANALGESIA QUIZ
PHYSICIAN PROCEDURAL SEDATION AND ANALGESIA QUIZ 1. Which of the following statements are TRUE? (Select ALL that apply) o Sedative/analgesic drugs should be given in small, incremental doses that are titrated
More information2
1 2 3 4 5 6 7 8 Please check regional policy on Tetracaine and Morgan Lens this may be optional in your region. *Ketamine and Fentanyl must be added to your controlled substance license if required by
More informationEPIDURAL / INTRATHECAL POST-OP PLAN
EPIDURAL / INTRATHECAL POST-OP PLAN Diagnosis Weight PHYSICIAN S Allergies Patient Care Vital Signs Per Unit Standards, PLUS check and record RR q1h x 12, then q2h x 6, until 24h following narcotic administration.
More informationMEDICATIONS IN PREGNANCY
MEDICATIONS IN PREGNANCY If patient presents with significant past history of drug addiction pain control should be closely monitored due to increased tolerance to narcotics. Consult Pain Specialist and
More informationPediatric (BP, weight conversion) Information
Pediatric (BP, weight conversion) Information Reference Reviewed: Updated: Blood pressure Minimal systolic BP = 70 + (2 x age) Normal systolic BP = 90 + (2 x age) Estimation of Pediatric Weight (2 x age)
More informationPain: 1-2µg/kg q30-60min prn. effects in 10 minutes. Contraindications: Morphine is preferred in. Duration of Action: minutes. renal failure.
Procedural Sedation / Analgesia / Anaesthesia Chart - Page 1 Diazepam (Valium) Anxiolytic / Sedative Etomidate (Amidate) Hypnotic / Anesthetic Fentanyl Citrate (Sublimaze) Narcotic Analgesic Dose Pediatric:
More informationBC Cancer Protocol Summary for Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
BC Cancer Protocol Summary for Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Protocol Code Tumour Group Contact Physician HNLACETRT Head and
More informationGENERAL SURGERY POST-OP PLAN
GENERAL SURGERY POST-OP PLAN PHYSICIAN S Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards Patient Activity Up Ad Lib/Activity as Tolerated Assist as Needed Bedrest Bedrest Bathroom
More informationPHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG
Available at: BMC-B BMC-D BMC-N BMC-S Activity Activity Bedrest with BRP, with assistance at nurse's discretion (DEF)* Ambulate with Assistance Diet Communication Order Patient to remain NPO while in PACU
More informationRespiratory Depression
Respiratory Depression H. William Gottschalk, D.D.S. Fellow, Academy of General Dentistry Fellow, American Dental Society of Anesthesiology Diplomate, American Board of Dental Anesthesiology Diplomate,
More informationAtropine Sulfate Injection
http://www.ashp.org/menu/practicepolicy/resourcecenters/drugshortages/currentshortages.aspx Atropine Sulfate Injection [10 April 2012] Atropine injection, Hospira 0.05 mg/ml, 5 ml Ansyr syringe, package
More informationAdult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES
Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal
More informationPEDIATRIC LIFEGIFT BRAIN DEATH PLAN
PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING. Patient Status Pt Status: Inpatient (Inpatient only
More informationAttestation for Completion of Procedural Sedation Course for Level I Moderate Procedural Sedation Privileges
Attestation for Completion of Procedural Sedation Course for Level I Moderate Procedural Sedation Privileges I certify that I have completed the following: I have read the PHSW Procedural Sedation Policy
More informationResuscitation Fluids
Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be
More informationPHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older)
Name Score PHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older) 1. Pre-procedure evaluation for moderate sedation should involve all of the following EXCEPT: a) Airway Exam b) Anesthetic history
More informationMARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa
MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.44 Subject: Policy: Purpose: Moderate (Conscious) Sedation Conscious sedation will be ordered
More informationThe following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.
Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse
More informationWEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code
(Page 1 of 5) Code Status Full code Status/Admit/Transfer/Discharge Surgical Procedure(s) and date performed: Cardiologist: Cardiac Surgeon: Intensivist: Patient Care CMV status Recipient CMV status Donor
More informationTitle/Description: Department: Personnel: Effective Date: Revised: PURPOSE DEFINITIONS
Title/Description: Moderate Sedation and Anesthesia Care Department: Organization-wide Personnel: All Individuals Involved in Anesthesia Care Effective Date: 9/90 Revised: 3/94, 12/96, 4/00, 11/02, 02/03,
More informationGazyva (obinutuzumab)
STRENGTH DOSAGE FORM ROUTE GPID 1000mg/40mL Vial Intravenous 35532 MANUFACTURER Genentech, Inc. INDICATION(S) Gazyva (obinutuzumab) is a CD20- directed cytolytic antibody and is indicated, in combination
More informationADENOSINE. ADRENALINE (Epinephrine)
ADENOSINE Notes Arrhythmias I.V. Initial dose 150 micrograms/kg stat Increase dose if required by 50 micrograms/kg to a maximum of 300 micrograms/kg (or 500 micrograms/kg if over 28 days old) ADMINISTRATION
More informationSatisfactory Analgesia Minimal Emesis in Day Surgeries. (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone
Satisfactory Analgesia Minimal Emesis in Day Surgeries (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone HARSHA SHANTHANNA ASSISTANT PROFESSOR ANESTHESIOLOGY MCMASTER UNIVERSITY
More informationParamedic Pediatric Medical Math Practice
Paramedic Pediatric Medical Math Practice Name: Date: Problem 1 Your 4 year old patient weighs 40 pounds. She is febrile. You need to administer acetaminophen (Tylenol) 15mg/kg. How many mg will you administer?
More informationClinical Pathway: Management Of The Life-Threatening Overdose
Clinical Pathway: Management Of The Life-Threatening Overdose Intravenous access Oxygen Pulse oximetry n-invasive blood pressure monitoring Accu-Check ECG monitoring and ECG Chest x-ray Respiratory depression?
More informationWest Penn Allegheny Health System Forbes Regional Hospital
Policy Name: Treatment of Anaphylactic Reaction In the Cath Lab Original Date: West Penn Allegheny Health System Forbes Regional Hospital Policy No. 16553 Page 1 of 6 Reviewed by : Mark Taylor, MD, Michael
More informationNassau Regional Emergency Medical Services. Advanced Life Support Pediatric Protocol Manual
Nassau Regional Emergency Medical Services Advanced Life Support Pediatric Protocol Manual 2014 PEDIATRIC ADVANCED LIFE SUPPORT PROTOCOLS TABLE OF CONTENTS Approved Effective Newborn Resuscitation P 1
More informationVENTRICULAR FIBRILLATION. 1. Safe scene, standard precautions. 2. Establish unresponsiveness, apnea, and pulselessness. 3. Quick look (monitor)
LUCAS COUNTY EMS SUMMARY PAGES VENTRICULAR FIBRILLATION 2. Establish unresponsiveness, apnea, and pulselessness 3. Quick look (monitor) 4. Identify rhythm 5. Provide 2 minutes CPR if unwitnessed by EMS
More informationmorphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice
PATIENT CONTROLLED ANALGESIA (PCA) PLAN Allergies: Medication Selection: morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice HYDROmorphone (Dilaudid ) 6 mg/ 30 ml (0.2 mg/ml) fentanyl 300 mcg/ 30 ml (10 mcg/ml)
More informationSTATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014
STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014 2 [300] S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL
More informationPEDIATRIC EMERGENCY CARE GUIDE Child 70mm. Child 70mm
PEDIATRIC EMERGENCY CARE GUIDE Pediatric Parameters & Equipment Age Neonate 3mo 6mo 1 yr 2 yr 3 yr 4 yr 6 yr 8 yr 12 yr 14 yr Wt (kg) 3.5 6 8 10 12 14 16 20 25 40 50 ~ BSA (m 2 ) 0.24 0.34 0.42 0.49 0.56
More informationINTRAVENOUS LIDOCAINE INFUSIONS AND INTRALIPID RESCUE
INTRAVENOUS LIDOCAINE INFUSIONS AND INTRALIPID RESCUE Acute Pain Service-LHSC VH and UH sites HISTORY Lidocaine and procaine used by IV infusion in the 1950s and 1960s for general analgesia Often continued
More informationPICU BRONCHIOLITIS PLAN
PICU BRONCHIOLITIS PLAN Diagnosis Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Pt Status: Inpatient (LOS > 2 midnights) Pt Status: Observation (LOS < 2 midnights) Patient Care Code
More informationUMC Health System Patient Label Here. PHYSICIAN ORDERS Diagnosis
PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer Patient Status Requested Location: NICU, Pt Status: Inpatient (LOS > 2 midnights) Pt Status: Observation (LOS < 2 midnights) Pt Status: Inpatient
More informationULYRICE. Protocol Code. Lymphoma. Tumour Group. Dr. Laurie Sehn. Contact Physician
BCCA Protocol Summary for the Treatment of Relapsed or Refractory Advanced Stage Aggressive B-Cell Non-Hodgkin s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and rituximab Protocol Code Tumour Group
More informationPediatric Procedural Sedation
Pediatric Procedural Sedation Case 1: 2 year old complex facial laceration Judith R. Klein, MD, FACEP Assistant Professor of Emergency Medicine UCSF-SFGH Department of Emergency Medicine Objectives: The
More informationALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS
DRUG AND TREATMENT Intubation Phase Notify Therapy for STAT intubation Medications SUB Rapid Sequence Induction (SUB)* ***Reminder: Order SUB Rapid Sequence Induction (SUB) on a separate form*** lidocaine
More informationSouth Dakota State Board of Dentistry PO Box 1079, 1351 N. Harrison Ave. Pierre, SD Ph: Fax:
South Dakota State Board of Dentistry PO Box 1079, 1351 N. Harrison Ave. Pierre, SD 57501-1079 Ph: 605-224-1282 Fax: 888-425-3032 E-mail: contactus@sdboardofdentistry.com www.sdboardofdentistry.com PRACTITIONER
More informationA00.2 Office of the Medical Director
A00.2 Office of the Medical Director 2017-07-17 Medications Individual license holders are responsible to hold and maintain the appropriate competencies (satisfactory knowledge and appropriate psychomotor
More informationSan Juan Islands EMS Meeting October 1, :00pm 1:00pm Zoom:
San Juan Islands EMS Meeting October 1, 2018 12:00pm 1:00pm Zoom: https://uw-phi.zoom.us/j/2065208962 INTRODUCTIONS: Dr. Pete McGough, Dr. Matt Jaffy, Dr. Mike Alperin, Dr. Mike Sullivan, Darren Layman,
More informationTherapeutic Hypothermia for Post Cardiac Arrest Plan Initial Orders
Arrest Plan Initial Orders Weight Allergies Therapeutic Hypothermia Guidelines ***Required to continue with ordering Plan.*** Strict Intake and Output q1h, throughout cooling and re warming. Set Up for
More informationBest Evidence: Australasian Guidelines for Management of Perioperative Anaphylaxis. Dr Helen Kolawole ANZAAG Management Guidelines Working Group
Best Evidence: Australasian Guidelines for Management of Perioperative Anaphylaxis Dr Helen Kolawole ANZAAG Management Guidelines Working Group Outline of Presentation Review of content of all Management
More informationNote: Press F11 to maximize. Physician Education Procedural Sedation for ESJH
Note: Press F11 to maximize. Physician Education Procedural Sedation for ESJH 1 Definitions along the Sedation Continuum Responsiveness Airway Spontaneous Ventilation Cardiovascular Function Minimal Sedation
More informationMICHIGAN. Table of Contents. State Protocols. General Treatment Protocols
MICHIGAN State Protocols General Treatment Protocols Table of Contents Protocol Number Protocol Name 1.1 General Pre-hospital Care: Regional Protocol 1.2 Abdominal Pain 1.3 Nausea and Vomiting: Regional
More informationPCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING
Attach ADR Sticker THESE INSTRUCTIONS EXPLAIN WHEN TO MAKE A CLINICAL REVIEW OR RAPID RESPONSE CALL, YOUR LOCAL ESCALATION PROTOCOL WILL EXPLAIN HOW TO MAKE A CALL PCA ALLERGIES & ADVERSE DRUG REACTIONS
More informationPAIN PODCAST SHOW NOTES:
PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of
More informationRituximab (weekly) for Primary Cutaneous B cell Lymphoma
Rituximab (weekly) for Primary Cutaneous B cell Lymphoma Indication: Palliative therapy for Low grade Primary Cutaneous B cell Lymphoma (Primary cutaneous Follicle centre cell Lymphoma and Primary cutaneous
More informationChange in Practice PCP Autonomous IV OBHG Education Subcommittee
Change in Practice PCP Autonomous IV Intravenous and Fluid Therapy Medical Directive Auxiliary Ability to initiate IV access and Ability to administer fluid and fluid boluses in general IV Therapy Actual
More informationPhysician Orders ADULT: Sickle Cell Inpatient Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: Sickle Cell Inpatient Phase, When to Initiate: When patient arrives to unit Sickle Cell Inpatient Phase Admission/Transfer/Discharge
More informationModerate and Deep Sedation Pathway
A Quick Reference to the Advocate System Sedation Policy *This information is meant as a guideline only and not a substitute for physician order or clinical judgment Introduction: This Pediatric Emergency
More informationMotion Approved by Council February 20, Revoke subsections 1 (2) and (3) and substitute the following:
Item 5.3 Motion Approved by Council February 20, 2015 Recommending that Council approve in principle the following amendments to O. Reg. 203/94, namely: 1. Revoke subsections 1 (2) and (3) and substitute
More informationAssessment. Consults & Referrals
University of Virginia Health System Clinical Pathway: Whipple Enhanced Recovery After () LOS: 4-5 days Date of Origin/Revision: June 29, 2016/September 6, 2017/January 31, 2018 : SAS : : : D1 D2 D 3/
More informationADMINISTRATION GUIDE
DOSING AND ADMINISTRATION GUIDE INDICATION LARTRUVO is indicated, in combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma (STS) with a histologic subtype for which
More informationDrug Dosage Practice Problems
Drug Dosage Practice Problems Topics covered: Metric Conversions -------------------------------------------------------------- page 2 General Conversions ------------------------------------------------------------
More information